BEHENTRIMONIUM CHLORIDE
화장품에서 베헨트라이모늄클로라이드 (BEHENTRIMONIUM CHLORIDE)의 글로벌 배합 한도와 핵심 효능·처방 기준은 무엇인가요?
베헨트라이모늄클로라이드(표준 INCI: BEHENTRIMONIUM CHLORIDE, CAS 번호: 17301-53-0)은 화장품 처방에서 주로 대전방지제, 모발컨디셔닝제, 방부제 목적으로 배합되는 핵심 원료입니다. 한국 식약처(제한) 및 유럽 CosIng(제한) 등 6대 권역 법정 기준 하에 관리되며, 통상 0.5–3%(적정 pH 4–8) 범위에서 안정적으로 처방됩니다.
7대 갈래 국가별·용도별 공식 전성분 라벨 표기명 매트릭스
각국 1차 법원 고시 정본 · 기계번역·임의 음차 0건| 국가·규제 트랙 | 공식 고시 전성분 표기명 | 원클릭 복사 |
|---|---|---|
| ① 한국 (MFDS 화장품 한글 표준명) | 베헨트라이모늄클로라이드 | |
| ② 한국 구명칭 (개정 전 이력 · 301 리다이렉트) | 베헨트리모늄클로라이드 | |
| ③ 유럽 (EU CosIng EC 1223/2009) | BEHENTRIMONIUM CHLORIDE | |
| ④ 미국 일반화장품 (US PCPC / MoCRA INCI) | BEHENTRIMONIUM CHLORIDE | |
| ⑤ 미국 OTC (FDA Active Ingredient Monograph) | — (비-OTC 일반 화장품 원료) | — |
| ⑥ 중국 (NMPA IECIC 표준 중문명) | 山嵛基三甲基氯化铵 | |
| ⑦ 일본 일반화장품 / 의약부외품 (JCIA / MHLW) | BEHENTRIMONIUM CHLORIDE (표준 INCI 기준 · 임의 가타카나 변환 배제) |
Layer 1 — 글로벌 6대 권역 법정 배합 한도 및 규제 상태
| 권역 | 규제 상태 | 배합 한도 | 제한 조건 및 1차 법원 출처 |
|---|---|---|---|
| 한국 (MFDS) | 제한 | GMP | 공식 화장품 원료 목록 등재 (GMP 기준 사용) |
| 유럽 (CosIng) | 제한 | GMP | 공식 화장품 원료 목록 등재 (GMP 기준 사용) |
| 미국 (FDA/CIR) | 미규제 | GMP | 공식 화장품 원료 목록 등재 (GMP 기준 사용) |
| 중국 (NMPA) | 등재·허용 | GMP | IECIC Entry #5956 |
| 일본 (MHLW) | 미규제 | GMP | 공식 화장품 원료 목록 등재 (GMP 기준 사용) |
| 아세안 (ACD) | 미규제 | GMP | 공식 화장품 원료 목록 등재 (GMP 기준 사용) |
Layer 2 — 독성·안전성 평가 한도 (US CIR · EU SCCS MoS≥100 · CN IECIC 최고역사사용량)
「SCCS 안전 판정 상한」은 유럽 소비자안전과학위원회가 안전역(MoS≥100)으로 판정한 상한이며, 「CIR 시판 보고 농도」와 「중국 IECIC 최고역사사용량」은 실제 시판 제품에 보고된 최대 농도입니다.
| 안전성 평가 기준 | 적용 부위·유형 | 안전 농도 범위 | 판정 결과 및 문헌 번호 |
|---|---|---|---|
| CIR 시판 보고 농도 | hair | 0.2~7% | 안전 판정(MoS≥100)115_draft_trimon.pdf () |
| CIR 시판 보고 농도 | spray | 0.2~1% | 안전 판정(MoS≥100)115_draft_trimon.pdf () |
| CIR 시판 보고 농도 | rinse_off | 3~3% | 안전 판정(MoS≥100)115_draft_trimon.pdf () |
| CIR 시판 보고 농도 | hair_dye | 2~3% | 안전 판정(MoS≥100)115_draft_trimon.pdf () |
| CIR 시판 보고 농도 | dermal | 0.5~0.9% | 안전 판정(MoS≥100)115_draft_trimon.pdf () |
| EU SCCS 안전 판정 상한 | rinse_off | ≤ 5% | 안전 판정(MoS≥100) () |
| EU SCCS 안전 판정 상한 | leave_on | ≤ 3% | 안전 판정(MoS≥100) () |
Layer 3 제형군별 통상 배합 농도(%) 레인지 & Layer 1 법정 한도 대조
Layer 3 — 제형군별 통상 배합 농도(n≥5 사분위수) & 물리화학·상용성 가이드
| 제형군 분류 | Min – Q1 – Median – Q3 – Max (%) | 처방 역할 및 기전 | Source ID |
|---|---|---|---|
| 제형군 C — 세정 워시오프 · 폼 · 샴푸 · 바디워시 | 0.5% · 1% · 2.175% · 2.5% · 3% | 린스오프 세정·클렌징 처방 계면 안정화 및 사용감 개선 | Global Starter Formulation Library Statistical Distribution (n=16, EVONIK 11 · GRANT 4 · SEPPIC 1) |
| 제형군 B — 유화 로션 · 에멀전 · 크림 (O/W · W/O) | 0.5% · 1.45% · 1.475% · 2.9% · 3% | 유화 로션·크림 제형 구조 형성 및 피부 컨디셔닝 | Global Starter Formulation Library Statistical Distribution (n=10, GRANT 10) |
각질층 장벽 투과 깊이 & 바이오 스피큘 경피전달(DDS) 시뮬레이션
단독 도포 시 각질층 세포간 지질(Brick & Mortar) 경로를 통해 확산됩니다. 500 Dalton 이상 친수성 분자는 각질층 표면에 주로 머물러 보습·보호막 역할을 수행합니다.
pH 안정성 스펙트럼(0~14) · 가열 한계 게이지 · HLB 콜로이드 상거동
권장 구간 밖(pH < 4 또는 pH > 8)에서는 가수분해·점도 저하·이온 탈리 위험이 증가합니다.
최대 50°C 가열 공정에서 열적 안정성이 유지됩니다.
세포·분자 타깃 작용 기전 플로우 다이어그램
권장 시너지(🟢 실선) & 배합 금기·주의(🔴 점선) 인터랙티브 관계도
🟢 초록색 시너지 원료 노드를 클릭하면 해당 원료 모노그래프로 즉시 이동하며, 🔴 붉은색 점선 노드를 클릭하면 화학적 상충(석출·변색·실활) 메커니즘을 표시합니다.
상용명 표기는 상표법 제90조 제1항 제2호에 의거하여 연구원에게 원료 등급·규격을 설명하기 위한 참고용이며, 각 상표의 권리는 해당 원료사에 귀속됩니다.
학술·독성·제형 종합 요약 (Tier 1~3 탄력 요약)
Tier 1 Synthesis이 원료에 매칭된 PubMed 동료심사 논문 초록과 공인 독성 보고서만으로 작성된 학술 요약입니다.
근거 동료심사 학술 논문 (미국 NIH PubMed) (4)
Electrokinetic analysis reveals common conditioner ingredient interactions with human hair [PMID: 41126531 · 2026]
This study aims to use electrokinetic analysis to investigate the deposition behaviour and conditioning efficacy of cationic surfactants on human hair, focusing on how surfactant structure, concentration and hair damage influence performance. It also aims to understand the mechanisms governing surfactant adsorption and their impact on hair manageability and health. This research employed streaming potential measurements-including pH-dependent, time-dependent and concentration-dependent zeta (ζ)-potential studies-alongside wet combing analyses and ATR-FTIR spectroscopy to evaluate the adsorption affinity and conditioning effects of four cationic surfactants: behentrimonium chloride (BTMC), behentrimonium methosulfate (BTMS), hexadecyltrimethylammonium chloride (CTAC) and stearylalkonium chloride (STAC). A simplified model surface using silicon oxide (Si | SiO 2 ) wafers was also utilized to isolate the influence of hair's natural variability and fibrous structure. Longer-chain surfactants like BTMC showed superior deposition and conditioning due to stronger van der Waals interactions, while bulky groups in STAC hindered deposition. BTMC outperformed BTMS, likely due to the chloride counterion's higher mobility. BTMC and BTMS were superior against CTAC and STAC due to their longer carbon chain length. Wet combing analyses revealed that BTMC significantly reduced combing forces, improving manageability, whereas STAC fared the worst due to its low adsorption. However, ATR-FTIR analysis indicated no reversal of oxidative damage, suggesting conditioners improve manageability without repairing structural damage. The study highlights the importance of surfactant molecular structure-such as carbon chain length and counterion type-in deposition efficiency and conditioning performance, providing valuable insights for developing more effective hair care formulations. By leveraging electrokinetic analyses in the form of streaming potential experiments, we were able to quantitatively assess adsorption behaviour, ζ-potential changes and the dynamic interactions between surfactants and hair. These findings enhance the understanding of cationic surfactant-hair interactions, offering practical implications for optimizing conditioners to improve user experience and hair health. Cette étude vise à utiliser une analyse électrocinétique pour évaluer le comportement de dépôt et l'efficacité de conditionnement des tensioactifs cationiques sur les cheveux humains, en se concentrant sur la façon dont la structure et la concentration des tensioactifs et le degré de dommage capillaire influencent les performances. Elle vise également à comprendre les mécanismes qui régissent l'adsorption des tensioactifs et leur impact sur la facilité de coiffage et la santé des cheveux. MÉTHODES: Cette recherche a utilisé des mesures du potentiel de diffusion (études de potentiel zêta [ζ] en fonction du pH, du temps et de la concentration), ainsi que des analyses de peignage humide et une spectroscopie ATR‐FTIR pour évaluer l'affinité d'adsorption et les effets de conditionnement de quatre tensioactifs cationiques: chlorure de béhentrimonium (BTMC), méthosulfate de béhentrimonium (BTMS), chlorure d'hexadécyltriméthylammonium (CTAC) et chlorure de stéaralkonium (STAC). Un modèle de surface simplifié utilisant des plaquettes d'oxyde de silicium (Si |SiO 2 ) a également été utilisé pour isoler l'influence de la variabilité naturelle des cheveux et de la structure de la fibre capillaire. RÉSULTATS: Les tensioactifs à longue chaîne, comme le BTMC, ont montré un dépôt et un conditionnement supérieurs en raison d'interactions de Van der Waals plus fortes, tandis que les groupes volumineux en STAC ont limité le dépôt. Le BTMC a surp
Investigation of the interactions of cationic guar with human hair by electrokinetic analysis [PMID: 33811764 · 2021]
Cationic guar is an important polysaccharide used as a hair conditioning agent in personal care products. In this article, we report streaming potential data demonstrating its behaviour as it interacts electrostatically with hair. Several cationic guar variants with different molecular weights (MWs) and charge densities (CDs) were examined. All experiments were carried out with a custom-designed streaming potential instrument so that in situ, real-time data were monitored during the treatment of a hair plug with aqueous solutions of cationic guar and subsequent treatment with anionic surfactants-sodium laureth sulfate (SLES) and cocamidopropyl betaine (CAPB)-commonly found in contemporary shampoo formulations. The MW of the cationic guar variants plays an integral role in determining the thickness of the adsorbed polymer layer on the hair surface while CD influences the zeta potential. Data were also generated for the treatment of hair with a cationic flexible polymer (polyquaternium-28) and cationic conditioning surfactant (behentrimonium chloride) to provide a frame of reference. The deposition behaviour on hair of high MW cationic guar variants is distinct from these conventional molecules in terms of its electrokinetic properties. We also examined the electrokinetic behaviour of cationic guar on hair types from different racial backgrounds. While the cationic guar treatment yielded similar results for the different hair types, anionic surfactant treatment resulted in quicker sorption and desorption from African, European 65% grey, and Mulatto hair as compared to Chinese, European dark brown, and Indian hair. We introduce an in situ technique for measuring the dynamic sorption/desorption of charged molecules on the surface of human hair. Evaluation of a series of cationic guar species revealed varying behaviour depending on the MW and CD of the polysaccharide. Our data also demonstrate differences in the desorption properties of typical shampoo surfactants for hair from diverse racial backgrounds. Le guar cationique est un polysaccharide important utilisé comme conditionneur capillaire dans les produits cosmétiques. Dans ce rapport, nous démontrons l'utilisation de la technique du potentiel de streaming pour étudier comment le guar cationique interagit électrostatiquement avec les cheveux. Plusieurs variantes del guar cationique avec différents poids moléculaires et densités de charge ont été examinés. MÉTHODES: Nous avons utilisé un instrument de potentiel de streaming pour les expériences. Les études ont été réalisées en temps réel pour surveiller le traitement de cheveu avec des solutions aqueuses de guar cationique suivi d'un traitement ultérieur avec tensioactifs anioniques comment le sulfate de laureth de sodium et le cocamidopropyle bétaïne, des ingrédients généralement trouvés dans les formulations de shampooing. RÉSULTATS: Le poids moléculaire des variants du guar cationique joue un rôle intégral dans la détermination l'épaisseur de la couche de polymère adsorbée sur la surface des cheveux tandis que le densité de charge influence le potentiel zêta. Des données ont également été générées pour le traitement des cheveux avec un polymère flexible (polyquaternium-28) et tensioactif de conditionnement cationique (behentrimonium chlorure) pour fournir un cadre de référence. Le comportement de dépôt sur les cheveux des variants de guar cationiques à poids moléculaire élevé est distinct de ces molécules conventionnelles en termes de ses propriétés électrocinétiques. Nous avons également examiné le comportement électrocinétique de guar cationique sur des types de cheveux de différents milieux raciaux. Le traitement
Confirmation of in vitro and clinical safety assessment of behentrimonium chloride-containing leave-on body lotions using post-marketing adverse event data. [PMID: 24064305 · 2013]
Behentrimonium chloride (BTC) is a straight-chain alkyltrimonium chloride compound commonly used as an antistatic, hair conditioning, emulsifier, or preservative agent in personal care products. Although the European Union recently restricted the use of alkyltrimonium chlorides and bromides as preservatives to ≤0.1%, these compounds have been safely used for many years at ≤5% in hundreds of cosmetic products for other uses than as a preservative. In vitro, clinical, and controlled consumer usage tests in barrier-impaired individuals were conducted to determine if whole body, leave-on skin care products containing 1-5% BTC cause dermal irritation or any other skin reaction with use. BTC-containing formulations were predicted to be non-irritants by the EpiDerm® skin irritation test and the bovine corneal opacity and permeability (BCOP)/chorioallantoic membrane vascular assay (CAMVA) ocular irritation test battery. No evidence of allergic contact dermatitis or cumulative dermal irritation was noted under the exaggerated conditions of human occlusive patch tests. No clinically assessed or self-reported adverse reactions were noted in adults or children with atopic, eczematous, and/or xerotic skin during two-week and four-week monitored home usage studies. These results were confirmed by post-marketing data for five body lotions, which showed only 0.69 undesirable effects (mostly skin irritation) reported per million shipped consumer units during 2006-2011; a value consistent with a non-irritating body lotion. No serious undesirable effects were reported during in-market use of the products. Therefore, if formulated in appropriate conditions at 1-5%, BTC will not cause dermal irritation or delayed contact sensitization when used in a whole-body, leave-on product.
Repeatability of Quantitative Diffusion-Weighted Imaging Metrics in Phantoms, Head-and-Neck and Thyroid Cancers: Preliminary Findings [PMID: 30854438 · 2019]
The aim of this study was to establish the repeatability measures of quantitative Gaussian and non-Gaussian diffusion metrics using diffusion-weighted imaging (DWI) data from phantoms and patients with head-and-neck and papillary thyroid cancers. The Quantitative Imaging Biomarker Alliance (QIBA) DWI phantom and a novel isotropic diffusion kurtosis imaging phantom were scanned at 3 different sites, on 1.5T and 3T magnetic resonance imaging systems, using standardized multiple b-value DWI acquisition protocol. In the clinical component of this study, a total of 60 multiple b-value DWI data sets were analyzed for test-retest, obtained from 14 patients (9 head-and-neck squamous cell carcinoma and 5 papillary thyroid cancers). Repeatability of quantitative DWI measurements was assessed by within-subject coefficient of variation (wCV%) and Bland-Altman analysis. In isotropic diffusion kurtosis imaging phantom vial with 2% ceteryl alcohol and behentrimonium chloride solution, the mean apparent diffusion (D app × 10 -3 mm 2 /s) and kurtosis (K app , unitless) coefficient values were 1.02 and 1.68 respectively, capturing in vivo tumor cellularity and tissue microstructure. For the same vial, D app and K app mean wCVs (%) were ≤1.41% and ≤0.43% for 1.5T and 3T across 3 sites. For pretreatment head-and-neck squamous cell carcinoma, apparent diffusion coefficient, D, D*, K, and f mean wCVs (%) were 2.38%, 3.55%, 3.88%, 8.0%, and 9.92%, respectively; wCVs exhibited a higher trend for papillary thyroid cancers. Knowledge of technical precision and bias of quantitative imaging metrics enables investigators to properly design and power clinical trials and better discern between measurement variability versus biological change.
자주 묻는 질문 (AEO 스니펫 최적화 FAQ)
- Q1. 베헨트라이모늄클로라이드 (BEHENTRIMONIUM CHLORIDE)의 국가별 공식 전성분 표기명은 어떻게 다른가요?
- 한국 식약처 표준명은 '베헨트라이모늄클로라이드', 미국 PCPC 및 유럽 CosIng INCI 표기는 'BEHENTRIMONIUM CHLORIDE', 중국 NMPA IECIC 표준명은 '山嵛基三甲基氯化铵', 일본 화장품 표시명칭은 'BEHENTRIMONIUM CHLORIDE'입니다.
- Q2. 베헨트라이모늄클로라이드의 글로벌 6대 권역 법정 배합 한도(Layer 1)는 무엇인가요?
- 한국(KR: restricted), 유럽(EU: restricted), 미국(US: none), 중국(CN: allowed), 일본(JP: none), 아세안(ASEAN: none) 고시 기준을 준수하여 처방해야 합니다.
- Q3. 제형 설계 시 베헨트라이모늄클로라이드의 통상 배합 농도(Layer 3)와 적정 pH는 얼마인가요?
- 대표 제형군(cleanser_rinse) 기준 통상 0.5~3%(권장 중앙값 2.175%) 범위로 투입하며, 적정 pH는 4~8입니다.
- Q4. 베헨트라이모늄클로라이드 배합 시 주의해야 할 상용성 금기(Incompatibilities)와 시너지 성분은 무엇인가요?
- 주요 권장 시너지 조합은 GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, TOCOPHEROL이며, 배합 주의사항은 처방 내 극단적 pH 조건 및 고농도 전해질과의 상용성 사전 확인 권장입니다.